About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

B-277733 1 (1997-10-27)

handle is hein.gao/gaocrptagdl0001 and id is 1 raw text is: 


oComptroller General
             of the United States
             Washington, D.C. 20548
             Decision





             Matter of: Pfizer, Inc.

             File:       B-277733

             Date:        October 27, 1997

             Kenneth B. Weckstein, Esq., and Shlomo D. Katz, Esq., Epstein, Becker & Green,
             P.C., for the protester.
             David C. Hammond, Esq., W. Bruce Shirk, Esq., and Mary Baroody Lowe, Esq.,
             Powell, Goldstein, Frazer & Murphy LLP, for the Bayer Corporation, an intervenor.
             Maura C. Brown, Esq., and Philip S. Kauffman, Esq., Department of Veterans Affairs,
             for the agency.
             Mary G. Curcio, Esq., and John M. Melody, Esq., Office of the General Counsel,
             GAO, participated in the preparation of the decision.
             DIGEST

             Agency properly may seek offers of two different formulations of a drug under a
             single solicitation, and make a single award based on low price, where agency
             determines that either formulation will meet its needs.
             DECISION

             Pfizer, Inc. protests solicitation No. M5-Q5-97, issued by the Department of Veterans
             Affairs (VA) for long-acting nifedipine. Pfizer principally argues that the solicitation
             improperly provides for a single award for long-acting nifedipine, ignoring the
             differences between two competing nifedipine products.

             We deny the protest.

             The solicitation was issued as part of a broader program underway at the VA to
             standardize pharmaceutical and medical/surgical items in order to achieve
             concentrated buying power by creating national formularies for various drugs.1
             The VA issued the solicitation here to establish a fixed-price contract for long-acting
             nifedipine tablets to be included on the national formulary. The solicitation
             provides for the award of a single contract based on low price.



             1The term national formulary refers to the VA's selection of a limited number of
             common drug items for unrestricted use by any prescriber. The selection of drugs
             for the national formulary is designed to standardize care for patients throughout
             the VA's national network of medical care facilities and to reduce costs.

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most